Bringing the fundamentals into focus…
Back to Charles River Laboratories International, Inc.
How Charles River Laboratories International, Inc. stacks up
CRL · against 1,216 other Healthcare companies
Growth
29/ 100
Below the middle of the pack.
Ranked #859 of 1,217 · scores higher than 29% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 20–29, including CRL · Click a bar to see the companies
Why growth scores 29?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 71% of peers. Revenue growth: -0.9% vs peer median 6.1%
- slower revenue growth over three years: weaker than 70% of peers. 3-year revenue growth: 0.3% vs peer median 5.8%
- Earnings per share growth is not reported, so it is left out of the score.
Metric by metric
Position: dot = CRL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CRL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -0.9% | 6.1% | 29% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 0.3% | 5.8% | 30% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around CRL| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 859 | 6.0B CNY (≈$840M) | 29 | 45 | |
| 859 | 1.6B HKD (≈$209M) | 29 | 54 | |
| 859 | 1.3B USD | 29 | 15 | |
| 859 | 318M USD | 29 | 26 | |
| 859 | 16.9B USD | 29 | 37 | |
| 859 | 60M USD | 29 | 33 | |
| 859 | 64.8B EUR (≈$71.3B) | 29 | 51 | |
| 859 | 18.2B USD | 29 | 40 | |
| 859 | 1.7B USD | 29 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score